Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.

Volume: 21, Issue: 2, Pages: 649 - 662
Published: Mar 23, 2020
Abstract
Drugs produce their therapeutic effects by modulating specific targets, and there are 89 innovative targets of first-in-class drugs approved in 2004-17, each with information about drug clinical trial dated back to 1984. Analysis of the clinical trial timelines of these targets may reveal the trial-speed differentiating features for facilitating target assessment. Here we present a comprehensive analysis of all these 89 targets, following the...
Paper Details
Title
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Published Date
Mar 23, 2020
Volume
21
Issue
2
Pages
649 - 662
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.